This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Healthcare Conference. Steve...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Cecilia McKenney, Senior Vice President and Chief Human Resources Officer (CHRO),...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS 2022 Global Healthcare Conference....
"2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health...
Our Media Statement about COVID-19 Testing This is an evolving situation. Please check back to this page periodically for the latest information For more information, members of the media may...
Blood Test for Early Detection of Alzheimer's Disease (AD) Risk Will Lead to Better Patient Care, Physicians Say; U.S. Adults Call for Earlier Evaluation and More Education Quest Introduces Widely...
First quarter revenues of $2.61 billion, down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92, down 15.6% from 2021; and adjusted diluted EPS of $3.22, down 14.4%...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has made several organizational changes and leadership appointments of seasoned...
New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Site Builds on Quest's Extended Care Services to Improve...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2022 financial results on Thursday, April...
Positivity for Cocaine and Marijuana Increase for Federally Mandated, Safety-Sensitive Workers Required to Test Under Federal Law Amid Widespread Recruiting and Retention Challenges, Drug...
Quest to employ its comprehensive menu of COVID-19 antibody test and data analytics services to support population health research across 45 states and Puerto Rico SECAUCUS, N.J., March 23, 2022...
The Quest Diagnostics Foundation today announced a $500,000 donation to Project HOPE to support its humanitarian crisis relief efforts in Ukraine and for Ukrainian refugees in Eastern Europe....
At Quest Diagnostics, our vision is “Empowering better health with diagnostic insights.” Our goal is to make this a healthier world – not just for some, but for all. As we near the two-year...
Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three states
Bronx, N.Y./Secaucus, N.J, Feb. 15, 2022: Green Bronx Machine, a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences, today...
-- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive Chairman
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its Board of Directors, as part of its ongoing leadership succession planning,...
- Full year revenues of $10.79 billion, up 14.3% from 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022...
Convenient, physician-guided medical insights help people manage health without a trip to the doctor's office
Quest Diagnostics (NYSE: DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a score of 100% on the Human Rights Campaign Foundation's 2022...
The ELF™ Test is the first and only prognostic blood test granted De Novo marketing authorization to assess disease progression in NASH patients.
The ELF Test is now available nationwide through collaborations with Labcorp and Quest Diagnostics.
TARRYTOWN, N.Y.--(BUSINESS WIRE)--The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive...
Quest Diagnostics to Support COVID-19 Testing for Illinois and Texas Long-Term Care Facilities’ Residents, Staff
WASHINGTON, DC (Jan. 26, 2022) - Project HOPE, a global health and humanitarian organization, is pleased to announce that Quest Diagnostics (NYSE: DGX), the world’s leading provider of...
Individuals may perform test in minutes in the comfort of their home, at their convenience
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of an at-home COVID-19 rapid antigen test service for consumer...
First-of-Its Kind Service Includes Robust Selection of Diagnostic Tests, Customizable for Men and Women, with Biometric Screening and a Health Risk Assessment to Provide a Health Quotient Score That Can Be Tracked Over Time
Adults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the...
Acquisition adds new capability in "Extended Care" services focused on engaging patients beyond traditional healthcare settings to improve outcomes and lower costs
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement to acquire Pack Health in an...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the fourth quarter and full year...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2021 financial results on...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 40th Annual J.P. Morgan Healthcare...
Junior Achievement of New Jersey (JANJ) virtually held its 19th annual New Jersey Business Hall of Fame™ on Thursday, December 9, 2021. The 2021 Laureates included John E. Harmon, Sr., IOM,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2021 Workplace...
Acquisition to broaden physicians' access to diagnostic services and deepen company's presence in the Southeast
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has acquired substantially all assets of Labtech Diagnostics, an independent...
Targeted Lung Panel Now Available with Physician's Order at Quest's 2,200 Patient Service Centers Nationwide
Physicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics (NYSE: DGX), the nation's leading provider of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
First-of-its-kind study reveals nearly three in four physicians believe telehealth visits limit the ability to determine if patients are at risk for or are already misusing prescription drugs
A new Health Trends® report from Quest Diagnostics (NYSE: DGX) finds that almost 70% of physicians fear they missed signs of drug misuse during the pandemic, and, given how the global health...
SECAUCUS, N.J., (DATE) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized as one of the World's Best Employers of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 30th Annual Healthcare...
For the last twenty months, 50,000 Quest colleagues have given their all every day to support our nation through the COVID-19 crisis. The experience has shown the character of our company—and...
Professional development program strives to eliminate health disparities among underserved populations by cultivating a pipeline of minority scholars for leadership roles in healthcare
KANSAS CITY, MO, NOVEMBER 2, 2021 — The Bluford Healthcare Leadership Institute (BHLI), committed to eliminating health disparities among minority and vulnerable populations, recently hosted its...
- Third quarter revenues of $2.77 billion, down 0.4% from 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2021. "We...
Over 1,150 school districts in Texas can elect to participate in the testing program
Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced it has formed an agreement with the Texas Department of State Health Services (DSHS)...
As the First Laboratory to Validate Ki-67 IHC MIB-1 pharmDx (Dako Omnis), Quest Plans to Make Testing Available Nationally by the End of October
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx...
Advanced Technology and Automation Delivers Quality Lab Results to Physicians and Patients in Seven States
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, has completed its integration of Northeast regional operations to its new 250,000 sq....
Quest Diagnostics makes more than $3 million commitment to American Heart Association efforts to expand research and mentorship opportunities for Black and Hispanic scholars, and drive hypertension management and COVID-19 relief
DALLAS, October 7, 2021 — The American Heart Association (AHA), the leading public health nonprofit devoted to a world of healthier lives for all -- through a significant commitment from Quest...
Onsite testing event will service more than 10,000 entrants, staff and volunteers to provide a safer environment for all
The Boston Athletic Association (B.A.A.) and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Quest will be the exclusive...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2021 financial results on Thursday, October...
Nationwide analysis of blood lead levels in children under six years of age finds ties between exposure, older homes, and poverty, and race
One in two (50.5%) American children under six years of age tested have detectable levels of lead, a toxic metal, in their blood, according to a new Health Trends® study from Quest Diagnostics...
Guests may schedule appointments for COVID-19 viral testing from Quest Diagnostics at 1,500 locations nationwide
Carnival Corporation & plc (NYSE/LSE: CCL;NYSE: CUK), the world's largest cruise company, today announced a new initiative making pre-board testing more convenient and accessible for its guests....
-- Revenues for full year 2021 now expected to be $9.84-$10.09 billion compared to the previous outlook of $9.54-$9.79 billion
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2021. Since the company reported its...
Nationwide analysis finds declines in the rate of new diagnoses of eight common cancers from March 2020-March 2021 versus prior to the pandemic suggesting a future wave of more advanced disease due to belated diagnoses
New diagnoses of eight common types of cancer (prostate, breast, colorectal, lung, pancreatic, cervical, gastric and esophageal) significantly declined during most of the first 13 months of the...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 19th Annual Global...
Physicians and patients to benefit from access to Quest’s industry-leading test menu and network of patient service centers throughout the state
SECAUCUS, N.J., and BOCA RATON, F.L. – August 24, 2021 – Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced it has acquired select assets of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director....
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
Testing can be performed by individuals from the comfort of their home, at their convenience, to encourage compliance and limit exposure in an office setting. New testing option complements Quest's current return-to-work solutions featuring molecular diagnostic and antibody testing
MIAMI and SECAUCUS, NJ, Aug. 11, 2021 (GLOBE NEWSWIRE) -- eMed™, a telehealth company democratizing healthcare through digital-point-of-care solutions, and Quest Diagnostics (NYSE: DGX), the...
North Charleston, S.C. — Select Health of South Carolina and Quest Diagnostics announced they have entered into an agreement that expands Select Health’s laboratory network for its Medicaid...
The clinic will offer integrated and multidisciplinary services for the care of patients who have suffered from COVID-19.
Salud Integral en la Montaña, Inc., (SIM) will expand its range of primary medical care with the first Post COVID-19 Care Clinic in Puerto Rico. In this clinic, patients will have access to a...
- Second quarter revenues of $2.55 billion, up 39.5% from 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2021. "We had...
Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers and live event attendance
CLX Health, developer of cloud-based solutions to manage the COVID-19 testing ecosystem with their TrustAssure™ Global Network, today announced a collaboration with Quest Diagnostics (NYSE:...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2021 Disability Equality Index® (DEI) Best Places to Work for...
Tackle Your Testing program will kick off this summer with free health events across Florida to provide diagnostic testing, education, nutritious meals and more to empower people to take control of their health.
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services today announced the Tackle Your Testing program to address the health disparities...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2021 financial results on Thursday, July...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released the Annual Corporate Responsibility Report for 2020. Titled "A Year of...
Physicians and patients will benefit from access to Quest's industry-leading test menu in Arkansas, Kansas, Missouri and Oklahoma
Quest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory services business of Mercy in an all-cash asset...
First Large-Scale National Analysis of Workforce Drug Testing During the COVID-19 Pandemic, Based on More Than 9 Million Drug Tests in 2020
The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce, according to a new analysis released...
Goal to develop regulatory-approved software products and services based on AI-generated insights from Quest's digital pathology diagnostic data
Quest Diagnostics (NYSE:DGX) and Paige today announced a collaboration designed to unlock the potential of artificial intelligence (AI) to improve and speed the diagnosis of cancer and other...
Collaboration utilizes digital content to educate children and inspire healthy outcomes
Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years. In the wake of COVID-19, low-income and...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference....
Eligibility for $0 out-of-pocket COVID-19 testing expanded to include adults and minors regardless of symptoms or suspected exposure, consistent with updated government guidance on insurance coverage for COVID-19 testing
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled several new enhancements to its COVID-19 testing services, with the goal to help...
In the Largest Study of its Kind, Findings Highlight the Need to Increase Hepatitis C Testing and Treatment to Decrease Rates of Transmission, Morbidity, and Mortality
A new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 pandemic reduced routine hepatitis C...
Combines Ginkgo's robust Concentric by Ginkgo pooled testing program with Quest's PCR/NAAT COVID-19 pooled specimen testing to support return to classrooms
Ginkgo Bioworks ("Ginkgo") today announced a collaboration with Quest Diagnostics (NYSE:DGX) to provide COVID-19 Kindergarten through Senior (K-12) school testing services to support classroom...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the BofA Securities 2021 Virtual Healthcare...
-- First quarter revenues of $2.72 billion, up 49.3% from 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2021. "Quest...
GENEVA--(BUSINESS WIRE)--The Commons Project Foundation and the World Economic Forum today announced the global expansion of the CommonTrust Network (www.commontrustnetwork.org) to cover 32...
10 studies highlight Quest Diagnostics' commitment to specialty genetics testing and research in areas such as mitochondrial mtDNA analysis and next generation sequencing
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced today that they will present results of 10 studies at the virtual...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on Thursday, April...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading...
Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
- Company to repurchase $900 million of its shares in first half of 2021
At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
Quest to acquire Mercy's outreach laboratory business serving providers and patients in Arkansas, Kansas, Missouri and Oklahoma
Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a...
-Quest will remain the exclusive, national clinical reference laboratory and testing provider for BlueCross BlueShield of Western New York and BlueShield of Northeastern New York members for all products-
SECAUCUS, N.J., March 2, 2021— BlueCross BlueShield of Western New York and BlueShield of Northeastern New York, two of New York’s leading insurance carriers, and Quest Diagnostics (NYSE:...
Collaboration empowers individuals to access professional medical advice, when and where they want it, for employer-sponsored laboratory and biometric screening
98point6, the on-demand digital primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country, today announced a collaboration with Quest...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids in providing insight into an individual's...
--Daniel C. Stanzione to Retire from Board and as Lead Independent Director
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione,...
-- Quest Diagnostics to Provide Blood Specimen Collection for Galleri Through its Patient Service Centers and Mobile Phlebotomists --
MENLO PARK, Calif.-- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with Quest Diagnostics (NYSE: DGX), the leading...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at Citi's 2021 Healthcare Services, Medtech,...
- Quest will remain the preferred national clinical reference laboratory and testing provider for EmblemHealth and ConnectiCare members for all products
EmblemHealth, one of the nation's largest non-profit health insurers, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, have renewed their...
Quest Diagnostics has been named a Best Place to Work for LGBTQ Equality by scoring a perfect 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI) for the fifth...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host a virtual Investor Day for institutional investors and financial analysts on Thursday,...
- Fourth quarter revenues of $3.0 billion, up 55.8% versus 2019
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 10.7% increase in its...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2021...
First COVID-19 testing event launched by a partnership among Quest Diagnostics, Choose Healthy Life and United Way of New York City at Harlem's historic Abyssinian Baptist Church
In response to the disproportionate and devastating impact COVID-19 has had on Black communities and other underserved communities of color, the first of many "Choose Healthy Life" COVID-19...
Leading public health officials Dr. Anthony Fauci, Dr. Marcella Nunez-Smith and Dr. Tom Frieden were among featured speakers and Q&A participants
Today, on Martin Luther King Jr. Day, a group of the nation's most renowned Black clergy led by Rev. Al Sharpton and Rev. Calvin O. Butts, III hosted the Choose Healthy Life Black Clergy Conclave....
By magnifying racial disparities in healthcare, COVID-19 has raised expectations for change
A new Quest Diagnostics Health Trends™ study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments...
Quest's genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into an agreement with the Centers for Disease Control and...
On Martin Luther King Jr. Day, one year after the last MLK Day saw the first confirmed case of COVID-19 in the United States, Choose Healthy Life, led by Rev. Al Sharpton and Rev. Calvin O. Butts,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on Thursday,...
Hackensack Meridian Health (HMH), the largest, most comprehensive and truly integrated health care network in New Jersey, and Quest Diagnostics (NYSE: DGX), the world's leading provider of...
